Drugs / Selenomethionine
Selenomethionine
also known as
L-Selenomethionine · SLM · 75se · NSC-760370 · Radioselenomethionine 75 se · Selenomethionine (75se) injection · Selenomethionine, l-, se-75 · Selenomethionine, se-75 · +1 more
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT01211561 | Dec 2010 → Dec 2014 | colorectal cancer | University of Illinois at Chicago | Unknown | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT04952129 | May 2022 → Dec 2023 | colorectal adenoma | University of Auckland, New Zealand | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT05363631 | Sep 2022 → Dec 2026 expected | clear cell renal carcinoma | Mohammed Milhem | Active not recruiting | No outcome recorded |
| Phase 1/2 | NCT02535533 | Jan 2016 → Aug 2023 | clear cell renal carcinoma | Mohammed Milhem | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01682031 | Jun 2009 → Apr 2012 | chemotherapy-induced toxicity, hypopharynx squamous cell carcinoma, laryngeal squamous cell carcinoma, lip and oral cavity squamous cell carcinoma +5 | Roswell Park Cancer Institute | Terminated | No outcome recorded |
| Phase 2 | NCT00455416 | Apr 2007 → Apr 2009 | follicular lymphoma | Oslo University Hospital | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00271427 | Dec 2004 → Aug 2005 | Hashimoto thyroiditis | Ege University | Completed | No outcome recorded |
| — | NCT00212186 | Oct 1998 → Nov 2003 | cirrhosis of liver | Vanderbilt University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07427017 Comparator | Apr 2026 → Dec 2028 expected | ulcerative colitis | Northwestern University | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00030901 Comparator | Feb 2000 → Nov 2011 | preneoplastic lesion, prostate cancer | SWOG Cancer Research Network | Completed | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | selenomethionine | “Patients and controls were randomly assigned to one of 3 treatment groups: 200 µg selenium per day as selenate, 200 µg selenium per day as selenomethionine, or a placebo.” NCT00212186 ↗6“Patients receive selenomethionine PO twice daily in week 1 and then once daily in weeks 2-11.” NCT01682031 ↗ “Patients enrolled in the study will receive 200 mcg selenomethionine daily” NCT07427017 ↗ |
| Known as | 75se | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | L-Selenomethionine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00455416 ↗ |
| Known as | NSC-760370 | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | Radioselenomethionine 75 se | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | Selenomethionine (75se) injection | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | Selenomethionine, l-, se-75 | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | Selenomethionine, se-75 | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | Selenometionina (75se) | ChEMBL registry synonym — accepted as the source's own label CHEMBL113178 ↗ |
| Known as | SLM | “Drug: Selenomethionine (SLM)” NCT05363631 ↗1“Selenomethionine (SLM)” NCT02535533 ↗ |
| Action | Inhibit | “L-selenomethionine may stop the growth of tumor cells by blocking the growth of new blood vessels necessary for tumor growth.” NCT02535533 ↗ |
| Modality | Other / unclassified | “Seleno-amino acid” NCT04952129 ↗ |
| Route | Oral | “L-selenomethionine (Selenium)one tablet by mouth daily for 3 years.” NCT00030901 ↗ |